PQS Phoqus

    RNS Number : 5941W
  Phoqus Pharmaceuticals PLC
  12 June 2008
   

    


    Result of AGM

    West Malling, UK, 12 June 2008: Phoqus Pharmaceuticals plc (AIM: PQS) ("Phoqus" or the "Company"), the speciality pharmaceutical
company, announces that at the Annual General Meeting of earlier today, all of the resolutions were duly passed. 

    Enquiries:

    Phoqus Pharmaceuticals                         Tel: 01732 870227
    Suzanne Smith, Company Secretary

    Nomura Code Securities Limited           Tel: 020 7776 1200
    Phil Walker

    About Phoqus Pharmaceuticals

    Phoqus Pharmaceuticals is a speciality pharmaceutical company that aims to develop differentiated products for use in high value,
specialist indications. Its first product candidate is Chronocort�, a novel physiological cortisol replacement therapy in development for
the treatment of patients with congenital adrenal hyperplasia and Addison's disease. 

    Further background on the Company can be found at www.phoqus.com. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
AGMBXGDLUXBGGID

Phoqus (LSE:PQS)
Historical Stock Chart
From May 2024 to Jun 2024

Phoqus (LSE:PQS)
Historical Stock Chart
From Jun 2023 to Jun 2024